Skip to main content

Table 3 Frequency of MIBC and NMIBC for VI-RADS Score for Each Reader

From: MRI evaluation of vesical imaging reporting and data system for bladder cancer after neoadjuvant chemotherapy

Variable

VI-RADS 1

VI-RADS 2

VI-RADS 3

VI-RADS 4

VI-RADS 5

Reader1(Experienced)

 No.of cases

6

6

11

10

13

 No.of cases with MIBC

0(0)

0(0)

2(18)

7(70)

12(92)

 No.of cases with NMIBC

6(100)

6(100)

9(82)

3(30)

1(8)

Reader2(Experienced)

 No.of cases

6

7

8

11

14

 No.of cases with MIBC

0(0)

0(0)

1(13)

6(55)

14(100)

 No.of cases with NMIBC

6(100)

7(100)

7(88)

5(45)

0(0)

Reader3(Experienced)

 No.of cases

6

7

9

11

13

 No.of cases with MIBC

0(0)

0(0)

1(11)

7(64)

13(100)

 No.of cases with NMIBC

6(100)

7(100)

8(89)

4(36)

0(0)

Reader4(Inexperienced)

 No.of cases

6

5

11

15

9

 No.of cases with MIBC

0(0)

0(0)

2(18)

10(67)

9(100)

 No.of cases with NMIBC

6(100)

5(100)

9(82)

5(33)

0(0)

Reader5(Inexperienced)

 No.of cases

6

7

7

16

10

 No.of cases with MIBC

0(0)

0(0)

2(29)

9(56)

10(100)

 No.of cases with NMIBC

6(100)

7(100)

5(71)

7(44)

0(0)

  1. Note—Values in parentheses are percentages of cases. MIBC Muscle-invasive bladder cancer, NMIBC Non–muscle-invasive bladder cancer, VI-RADS Vesical Imaging Reporting and Data System